World's Best Scientists 2026 revealed!
Parameswaran Nair

Parameswaran Nair

D-Index & Metrics

Microbiology

D-Index
62
Citations
18890
World Ranking
2830
National Ranking
76

Overview

Parameswaran Nair is affiliated with McMaster University in Canada and specializes in medical research, with a primary focus on pulmonary and respiratory medicine. Their scholarly activity encompasses 334 publications in medicine, with substantial contributions to several subfields including pulmonary and respiratory medicine, physiology, immunology, surgery, and rheumatology.

Their research mainly addresses topics within respiratory health and diseases, covering a range of key areas such as:

  • Asthma and respiratory diseases
  • Respiratory and cough-related research
  • Eosinophilic esophagitis
  • IL-33, ST2, and ILC pathways
  • Eosinophilic disorders and syndromes
  • Chronic obstructive pulmonary disease (COPD) research
  • Allergic rhinitis and sensitization

Parameswaran Nair's research output includes a number of recent papers demonstrating an emphasis on asthma and respiratory immune responses. Notable publications include:

  • "Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma" (2020, Allergy)
  • "EAACI Biologicals Guidelines-Recommendations for severe asthma" (2020, Allergy)
  • "Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long-COVID symptoms" (2022, European Respiratory Journal)
  • "Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis" (2022, The Journal of Allergy and Clinical Immunology In Practice)
  • "Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis/mycoses" (2024, European Respiratory Journal)

The scholar frequently collaborates with other researchers in their field. The five most frequent coauthors are:

  • Manali Mukherjee
  • Melanie Kjarsgaard
  • Sarah Svenningsen
  • Katherine Radford
  • Chynna Huang

Their work appears regularly in leading publication venues including:

  • Allergy
  • American Journal of Respiratory and Critical Care Medicine
  • CHEST Journal
  • European Respiratory Journal
  • Journal of Allergy and Clinical Immunology

In addition to journal articles, Parameswaran Nair has contributed to the book sector with a publication titled "Mucus plugging in severe asthma" (2025) under the European Respiratory Society.

Best Publications

  • Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia

    Parameswaran Nair;Marcia M M Pizzichini;Melanie Kjarsgaard;Mark D Inman

  • Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial

    J Mark FitzGerald;Eugene R Bleecker;Parameswaran Nair;Stephanie Korn

  • Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma.

    Klaus F. Rabe;Parameswaran Nair;Guy Brusselle;Jorge F. Maspero

  • Oral Glucocorticoid-Sparing Effect of Benralizumab in Severe Asthma.

    Parameswaran Nair;Sally Wenzel;Klaus F. Rabe;Arnaud Bourdin

  • Reslizumab for Poorly Controlled, Eosinophilic Asthma: A Randomized, Placebo-Controlled Study

    Mario Castro;Sameer Mathur;Frederick Hargreave;Louis-Philippe Boulet

  • Omalizumab for asthma in adults and children.

    Rebecca Normansell;Samantha Walker;Stephen J Milan;E. Haydn Walters

  • Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia.

    Steven G. Smith;Ruchong Chen;Ruchong Chen;Melanie Kjarsgaard;Chynna Huang

  • Role of Biologics in Asthma.

    Mary Clare McGregor;James G. Krings;Parameswaran Nair;Mario Castro

  • Safety and efficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutrophils: a randomized, placebo‐controlled clinical trial

    P. Nair;M. Gaga;E. Zervas;K. Alagha

  • Revisiting Type 2‐high and Type 2‐low airway inflammation in asthma: current knowledge and therapeutic implications

    D. Robinson;M. Humbert;R. Buhl;A. A. Cruz

  • Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma

    Ioana Agache;Jessica Beltran;Cezmi Akdis;Mubeccel Akdis

  • Addition of intravenous aminophylline to inhaled beta2-agonists in adults with acute asthma

    Parameswaran Nair;Stephen J Milan;Brian H Rowe

  • Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis.

    Unknown

  • Asthma Endotypes and an Overview of Targeted Therapy for Asthma.

    Sarah Svenningsen;Parameswaran Nair

  • Efficacy and safety of a CXCR2 antagonist, AZD5069, in patients with uncontrolled persistent asthma: a randomised, double-blind, placebo-controlled trial.

    Paul M O'Byrne;Hristo Metev;Margareta Puu;Kai Richter

  • Mechanisms and therapeutic strategies for Non‐T2 Asthma

    Eric Sze;Eric Sze;Anurag Bhalla;Parameswaran Nair

  • EAACI Biologicals Guidelines—Recommendations for severe asthma

    Ioana Agache;Cezmi Akdis;Mubeccel Akdis;Giorgio Walter Canonica

  • Methacholine test and the diagnosis of asthma.

    Donald W. Cockcroft;Parameswaran Nair

  • The definition and diagnosis of asthma.

    F. E. Hargreave;P. Nair

  • Weight-adjusted Intravenous Reslizumab in Severe Asthma with Inadequate Response to Fixed-Dose Subcutaneous Mepolizumab

    Manali Mukherjee;Fernando Aleman Paramo;Melanie Kjarsgaard;Brittany Salter

  • The Safety of Long-Acting β-Agonists among Patients with Asthma Using Inhaled Corticosteroids

    Roman Jaeschke;Paul M. O'Byrne;Filip Mejza;Parameswaran Nair

Frequent Co-Authors

Paul M. O'Byrne
Paul M. O'Byrne McMaster University
Frederick E. Hargreave
Frederick E. Hargreave McMaster University
Louis-Philippe Boulet
Louis-Philippe Boulet Université Laval
Qutayba Hamid
Qutayba Hamid University of Sharjah
James G. Martin
James G. Martin McGill University Health Centre
James J. Lee
James J. Lee Mayo Clinic
Catherine Lemière
Catherine Lemière University of Montreal
Gail M. Gauvreau
Gail M. Gauvreau McMaster University
Nikolaos G. Papadopoulos
Nikolaos G. Papadopoulos National and Kapodistrian University of Athens
Mohamed H. Shamji
Mohamed H. Shamji Imperial College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Microbiology in the USA opens doors to diverse healthcare careers. As the industry increasingly relies on digital data, roles such as health information management have grown in demand. Understanding the health information manager salary can offer valuable insight into potential earnings and career trajectories in this field.

For those interested in specialized education, exploring online health information management degree programs cahiim accredited is essential. Accreditation ensures quality and industry relevance, which is critical for advancing in medical data administration and compliance roles.

Additionally, quick certification pathways such as fast online medical billing and coding certification programs provide an efficient route to enter the healthcare administration sector. These certifications complement microbiology knowledge by enabling professionals to manage coding and billing with accuracy.

Broadening your scope, numerous online healthcare degrees allow for flexible learning and specialization. These options support career advancement by combining scientific expertise with healthcare management skills, making graduates highly competitive in the job market.

Best Scientists Citing Parameswaran Nair

Trending Scientists

Recently Published Articles